Institutul Oncologic Prof. Dr. Ion Chiricuţă

Cluj-Napoca, Cluj 400015

0 studies enrolling now · 2 studies all time

What they study most

ALK+ Advanced NSCLC, Breast Cancer

Studies at this site

• A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer — Completed
• Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer — Completed